A growing number of individuals are launching compensation claims against manufacturers of the heartburn medication Zantac. Complaints against the drug center around possible links to certaincancers, leading to a wave of claims. The US government has also phased out the sale of Zantac, contributing to concerns about its safety. Attorneys predict t